Overview

Update
IPO / Stock
Went Public on Jul 9, 2014 / NASDAQ:ROKA
Total Equity Funding
$109.5M in 4 Rounds from 5 Investors
Headquarters:
Warren, NJ
Description:
Roka Bioscience develops molecular assays and instrument systems for the food safety industry.
Founders:
Categories:
Food and Beverage, Health Care, Biotechnology
Website:
http://www.rokabio.com

Company Details

Update

Roka Bioscience is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry. Our newly released Atlas™ System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory.

Roka is focused on creating novel testing solutions that help manufacturers mitigate risks, protect their brands, and meet the increasing testing demands now and for years to come.

Funding Rounds (4) - $109.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2013$17M / Series E0
Jun, 2013$25M / Series E0
Jan, 2012$47.5M / Series D4
Jul, 2011$20M / Series C4

Current Team (7)

Update

Offices/Locations (1)

Update
  • Office

    20 Independence Boulevard

    4th Floor

    Warren, NJ 07059

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos